Entheon Biomedical CorpCanadian Securities Exchange:ENBIView on OTCQB
- LAST PRICE0.1350
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.1300/ 40
- Ask / Lots0.1350/ 3
- Open / Previous Close--- / 0.1350
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Entheon Biomedical Corp | 1.2M | -3.0x | --- |
HAVN Life Sciences Inc | 860.4K | 0.0x | --- |
Restart Life Sciences Corp | 1.2M | -1.9x | --- |
Waverley Pharma Inc | 810.0K | -0.2x | --- |
MYND Life Sciences Inc | 1.2M | -4.2x | --- |
Zenith Capital Corp | 786.8K | -1.3x | --- |
Company Information
Entheon Biomedical Corp. is a Canada-based biotechnology research and development company. The Company is interested in treating addiction and substance-use disorders.
Contact Information
- Headquarters
- Suite 720-999 W Broadway StreetVANCOUVER, BC, Canada V5Z 1K5
- Phone
- 604-562-3932
- Fax
- 514-718-5998
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.2M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 8.9M |
Entheon Biomedical Corp does not pay a dividend. | |
Beta | 1.65 |
EPS | $-0.05 |
Book Value | $0.05 |
P/E Ratio | -3.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
